Skip to main content
Top
Published in: Acta Neurologica Belgica 1/2016

01-03-2016 | Review Article

Nervous system Lyme disease, chronic Lyme disease, and none of the above

Author: John J. Halperin

Published in: Acta Neurologica Belgica | Issue 1/2016

Login to get access

Abstract

Lyme borreliosis, infection with the tick-borne spirochete Borrelia burgdorferi sensu lato, causes nervous system involvement in 10–15 % of identified infected individuals. Not unlike the other well-known spirochetosis, syphilis, infection can be protracted, but is microbiologically curable in virtually all patients, regardless of disease duration. Diagnosis relies on 2-tier serologic testing, which after the first 4–6 weeks of infection is both highly sensitive and specific. After this early, acute phase, serologic testing should rely only on IgG reactivity. Nervous system involvement most commonly presents with meningitis, cranial neuritis and radiculoneuritis, but can also present with a broader array of peripheral nervous system manifestations. Central nervous system infection typically elicits a cerebrospinal fluid pleocytosis and, often, intrathecal production of specific antibody, findings that should not be expected in disease not affecting the CNS. Treatment with recommended courses of oral or, when necessary, parenteral antibiotics is highly effective. The attribution of chronic, non-specific symptoms to “chronic Lyme disease”, in the absence of specific evidence of ongoing B. burgdorferi infection, is inappropriate and unfortunate, leading not only to unneeded treatment and its associated complications, but also to missed opportunities for more appropriate management of patients’ often disabling symptoms.
Literature
1.
go back to reference Benach JL, Bosler EM, Hanrahan JP et al (1983) Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med 308:740–742CrossRefPubMed Benach JL, Bosler EM, Hanrahan JP et al (1983) Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med 308:740–742CrossRefPubMed
2.
go back to reference Steere AC, Grodzicki RL, Kornblatt AN et al (1983) The spirochetal etiology of Lyme disease. N Engl J Med 308:733–740CrossRefPubMed Steere AC, Grodzicki RL, Kornblatt AN et al (1983) The spirochetal etiology of Lyme disease. N Engl J Med 308:733–740CrossRefPubMed
3.
go back to reference Asbrink E, Hederstedt B, Hovmark A (1984) The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer. Acta Derm Venereol 64:506–512PubMed Asbrink E, Hederstedt B, Hovmark A (1984) The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer. Acta Derm Venereol 64:506–512PubMed
4.
go back to reference Afzelius A (1921) Erythema chronicum migrans. Acta Derm Venereol (Stockh) 2:120–125 Afzelius A (1921) Erythema chronicum migrans. Acta Derm Venereol (Stockh) 2:120–125
6.
go back to reference Garin C, Bujadoux A (1922) Paralysie par les tiques. J Med Lyon 71:765–767 Garin C, Bujadoux A (1922) Paralysie par les tiques. J Med Lyon 71:765–767
7.
go back to reference Hollstrom E (1951) Successful treatment of erythema migrans Afzelius. Acta Derm Venereol 31:235–243PubMed Hollstrom E (1951) Successful treatment of erythema migrans Afzelius. Acta Derm Venereol 31:235–243PubMed
8.
go back to reference Steere AC, Malawista SE, Hardin JA, Ruddy S, Askenase W, Andiman WA (1977) Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Ann Intern Med 86:685–698CrossRefPubMed Steere AC, Malawista SE, Hardin JA, Ruddy S, Askenase W, Andiman WA (1977) Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Ann Intern Med 86:685–698CrossRefPubMed
9.
go back to reference Reik L, Steere AC, Bartenhagen NH, Shope RE, Malawista SE (1979) Neurologic abnormalities of Lyme disease. Medicine 58:281–294CrossRefPubMed Reik L, Steere AC, Bartenhagen NH, Shope RE, Malawista SE (1979) Neurologic abnormalities of Lyme disease. Medicine 58:281–294CrossRefPubMed
10.
go back to reference Ogrinc K, Lotric-Furlan S, Maraspin V et al (2013) Suspected early lyme neuroborreliosis in patients with erythema migrans. Clin Infect Dis 57:501–509CrossRefPubMed Ogrinc K, Lotric-Furlan S, Maraspin V et al (2013) Suspected early lyme neuroborreliosis in patients with erythema migrans. Clin Infect Dis 57:501–509CrossRefPubMed
11.
go back to reference Steere AC, Taylor E, Wilson ML, Levine JF, Spielman A (1986) Longitudinal assessment of the clinical and epidemiologic features of Lyme disease in a defined population. J Infect Dis 154:295–300CrossRefPubMed Steere AC, Taylor E, Wilson ML, Levine JF, Spielman A (1986) Longitudinal assessment of the clinical and epidemiologic features of Lyme disease in a defined population. J Infect Dis 154:295–300CrossRefPubMed
12.
go back to reference Wormser GP, Dattwyler RJ, Shapiro ED et al (2006) The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43:1089–1134CrossRefPubMed Wormser GP, Dattwyler RJ, Shapiro ED et al (2006) The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43:1089–1134CrossRefPubMed
13.
go back to reference Dattwyler RJ, Volkman DJ, Luft BJ, Halperin JJ, Thomas J, Golightly MG (1988) Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi. N Engl J Med 319:1441–1446CrossRefPubMed Dattwyler RJ, Volkman DJ, Luft BJ, Halperin JJ, Thomas J, Golightly MG (1988) Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi. N Engl J Med 319:1441–1446CrossRefPubMed
14.
go back to reference Dressler F, Yoshinari NH, Steere AC (1991) The T-cell proliferative assay in the diagnosis of Lyme disease [see comments]. Ann Intern Med 115:533–539CrossRefPubMed Dressler F, Yoshinari NH, Steere AC (1991) The T-cell proliferative assay in the diagnosis of Lyme disease [see comments]. Ann Intern Med 115:533–539CrossRefPubMed
15.
go back to reference Aguero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP (1996) Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol 34:1–9PubMedCentralPubMed Aguero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP (1996) Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol 34:1–9PubMedCentralPubMed
16.
go back to reference Dressler F, Whalen JA, Reinhardt BN, Steere AC (1993) Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 167:392–400CrossRefPubMed Dressler F, Whalen JA, Reinhardt BN, Steere AC (1993) Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 167:392–400CrossRefPubMed
17.
go back to reference Branda JA, Strle F, Strle K, Sikand N, Ferraro MJ, Steere AC (2013) Performance of United States serologic assays in the diagnosis of lyme borreliosis acquired in Europe. Clin Infect Dis 57:333–340CrossRefPubMed Branda JA, Strle F, Strle K, Sikand N, Ferraro MJ, Steere AC (2013) Performance of United States serologic assays in the diagnosis of lyme borreliosis acquired in Europe. Clin Infect Dis 57:333–340CrossRefPubMed
18.
go back to reference Wormser GP, Schriefer M, Aguero-Rosenfeld ME et al (2013) Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease. Diagn Microbiol Infect Dis 75:9–15PubMedCentralCrossRefPubMed Wormser GP, Schriefer M, Aguero-Rosenfeld ME et al (2013) Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease. Diagn Microbiol Infect Dis 75:9–15PubMedCentralCrossRefPubMed
19.
go back to reference Steere AC, McHugh G, Damle N, Sikand VK (2008) Prospective study of serologic tests for Lyme disease. Clin Infect Dis 47:188–195CrossRefPubMed Steere AC, McHugh G, Damle N, Sikand VK (2008) Prospective study of serologic tests for Lyme disease. Clin Infect Dis 47:188–195CrossRefPubMed
20.
go back to reference Rupprecht TA, Pfister HW, Angele B, Kastenbauer S, Wilske B. Koedel U (2005) The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Neurology 65(3): 448–450CrossRefPubMed Rupprecht TA, Pfister HW, Angele B, Kastenbauer S, Wilske B. Koedel U (2005) The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Neurology 65(3): 448–450CrossRefPubMed
21.
go back to reference Wilske B, Schierz G, Preac-Mursic V et al (1986) Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis. J Infect Dis 153:304–314CrossRefPubMed Wilske B, Schierz G, Preac-Mursic V et al (1986) Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis. J Infect Dis 153:304–314CrossRefPubMed
22.
go back to reference Henriksson A, Link H, Cruz M, Stiernstedt G (1986) Immunoglobulin abnormalities in cerebrospinal fluid and blood over the course of lymphocytic meningoradiculitis (Bannwarth's syndrome). Ann Neurol 20:337–345CrossRefPubMed Henriksson A, Link H, Cruz M, Stiernstedt G (1986) Immunoglobulin abnormalities in cerebrospinal fluid and blood over the course of lymphocytic meningoradiculitis (Bannwarth's syndrome). Ann Neurol 20:337–345CrossRefPubMed
23.
go back to reference Halperin JJ, Luft BJ, Anand AK et al (1989) Lyme neuroborreliosis: central nervous system manifestations. Neurology 39:753–759CrossRefPubMed Halperin JJ, Luft BJ, Anand AK et al (1989) Lyme neuroborreliosis: central nervous system manifestations. Neurology 39:753–759CrossRefPubMed
24.
go back to reference Logigian EL, Kaplan RF, Steere AC (1990) Chronic neurologic manifestations of Lyme disease. N Engl J Med 323:1438–1444CrossRefPubMed Logigian EL, Kaplan RF, Steere AC (1990) Chronic neurologic manifestations of Lyme disease. N Engl J Med 323:1438–1444CrossRefPubMed
25.
go back to reference Hammers-Berggren S, Hansen K, Lebech A-M, Karlsson M (1993) Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study. Neurology 43:169–175CrossRefPubMed Hammers-Berggren S, Hansen K, Lebech A-M, Karlsson M (1993) Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study. Neurology 43:169–175CrossRefPubMed
26.
go back to reference Marra CM, Tantalo LC, Sahi SK, Maxwell CL, Lukehart SA (2010) CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis. Sex Transm Dis 37:283–287PubMedCentralPubMed Marra CM, Tantalo LC, Sahi SK, Maxwell CL, Lukehart SA (2010) CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis. Sex Transm Dis 37:283–287PubMedCentralPubMed
27.
go back to reference Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I (2010) EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 17(8–16):e11–e14 Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I (2010) EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 17(8–16):e11–e14
28.
go back to reference Sillanpaa H, Skogman BH, Sarvas H, Seppala IJ, Lahdenne P (2013) Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children. Scand J Infect Dis 45:526–530CrossRefPubMed Sillanpaa H, Skogman BH, Sarvas H, Seppala IJ, Lahdenne P (2013) Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children. Scand J Infect Dis 45:526–530CrossRefPubMed
29.
go back to reference Rupprecht TA, Lechner C, Tumani H, Fingerle V (2014) CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine. Nervenarzt 85:459–464CrossRefPubMed Rupprecht TA, Lechner C, Tumani H, Fingerle V (2014) CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine. Nervenarzt 85:459–464CrossRefPubMed
30.
go back to reference Halperin JJ, Volkman DJ, Wu P (1991) Central nervous system abnormalities in Lyme neuroborreliosis. Neurology 41:1571–1582CrossRefPubMed Halperin JJ, Volkman DJ, Wu P (1991) Central nervous system abnormalities in Lyme neuroborreliosis. Neurology 41:1571–1582CrossRefPubMed
32.
33.
go back to reference Halperin JJ, Luft BJ, Volkman DJ, Dattwyler RJ (1990) Lyme neuroborreliosis—peripheral nervous system manifestations. Brain 113:1207–1221CrossRefPubMed Halperin JJ, Luft BJ, Volkman DJ, Dattwyler RJ (1990) Lyme neuroborreliosis—peripheral nervous system manifestations. Brain 113:1207–1221CrossRefPubMed
34.
go back to reference Belman AL, Iyer M, Coyle PK, Dattwyler R (1993) Neurologic manifestations in children with North American Lyme disease. Neurology 43:2609–2614CrossRefPubMed Belman AL, Iyer M, Coyle PK, Dattwyler R (1993) Neurologic manifestations in children with North American Lyme disease. Neurology 43:2609–2614CrossRefPubMed
35.
go back to reference Kan L, Sood SK, Maytal J (1998) Pseudotumor cerebri in Lyme disease: a case report and literature review. Pediatr Neurol 18:439–441CrossRefPubMed Kan L, Sood SK, Maytal J (1998) Pseudotumor cerebri in Lyme disease: a case report and literature review. Pediatr Neurol 18:439–441CrossRefPubMed
36.
go back to reference Ackermann R, Gollmer E, Rehse KB (1985) Progressive Borrelia encephalomyelitis. Chronic manifestation of erythema chronicum migrans disease of the nervous system. Dtsch Med Wochenschr 110:1039–1042CrossRefPubMed Ackermann R, Gollmer E, Rehse KB (1985) Progressive Borrelia encephalomyelitis. Chronic manifestation of erythema chronicum migrans disease of the nervous system. Dtsch Med Wochenschr 110:1039–1042CrossRefPubMed
37.
go back to reference Halperin JJ, Krupp LB, Golightly MG, Volkman DJ (1990) Lyme borreliosis-associated encephalopathy. Neurology 40:1340–1343CrossRefPubMed Halperin JJ, Krupp LB, Golightly MG, Volkman DJ (1990) Lyme borreliosis-associated encephalopathy. Neurology 40:1340–1343CrossRefPubMed
38.
go back to reference Klempner MS, Hu LT, Evans J et al (2001) Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 345:85–92CrossRefPubMed Klempner MS, Hu LT, Evans J et al (2001) Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 345:85–92CrossRefPubMed
39.
go back to reference Krupp LB, Hyman LG, Grimson R et al (2003) Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 60:1923–1930CrossRefPubMed Krupp LB, Hyman LG, Grimson R et al (2003) Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 60:1923–1930CrossRefPubMed
40.
go back to reference Fallon BA, Keilp JG, Corbera KM et al (2008) A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 70:992–1003CrossRefPubMed Fallon BA, Keilp JG, Corbera KM et al (2008) A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 70:992–1003CrossRefPubMed
41.
go back to reference Oksi J, Nikoskelainen J, Hiekkanen H et al (2007) Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study. Eur J Clin Microbiol Infect Dis 26:571–581CrossRefPubMed Oksi J, Nikoskelainen J, Hiekkanen H et al (2007) Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study. Eur J Clin Microbiol Infect Dis 26:571–581CrossRefPubMed
42.
go back to reference Halperin JJ, Shapiro ED, Logigian EL et al (2007) Practice parameter: treatment of nervous system Lyme disease. Neurology 69:91–102CrossRefPubMed Halperin JJ, Shapiro ED, Logigian EL et al (2007) Practice parameter: treatment of nervous system Lyme disease. Neurology 69:91–102CrossRefPubMed
43.
go back to reference Miklossy J, Kasas S, Zurn A, McCall S, Yu S, McGeer P (2008) Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis. J Neuroinflammation 5. doi:10.1186/1742-2094-5-40 Miklossy J, Kasas S, Zurn A, McCall S, Yu S, McGeer P (2008) Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis. J Neuroinflammation 5. doi:10.​1186/​1742-2094-5-40
Metadata
Title
Nervous system Lyme disease, chronic Lyme disease, and none of the above
Author
John J. Halperin
Publication date
01-03-2016
Publisher
Springer Milan
Published in
Acta Neurologica Belgica / Issue 1/2016
Print ISSN: 0300-9009
Electronic ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-015-0541-x

Other articles of this Issue 1/2016

Acta Neurologica Belgica 1/2016 Go to the issue